期刊文献+

不同糖耐量状态下老年男性高血压患者窦性心律震荡的临床意义 被引量:2

The clinical change in heart rate turbulence in elderly male hypertensive patients with different glucose tolerance
下载PDF
导出
摘要 目的探讨胰岛素抵抗与老年男性原发性高血压患者窦性心律震荡的(HRT)关系。方法将70例老年原发性高血压患者根据葡萄糖耐量试验结果分为高血压糖耐量正常组(EH+NGT)30例,糖耐量异常组(EH+IGT)20例和2型糖尿病组(EH+T2DM)20例,再进行24小时12导联同步动态心电图检测,计算HRT的震荡初始(TO)和震荡斜率(TS),对TO、TS与24 h正常窦性心律RR间期的标准差(SDNN)及左室舒张末内径(LEVDD)进行相关性分析。结果 EH+T2DM组TO、胰岛素抵抗指数(HOMA-IR)明显高于EH+IGT组、EH组(P<0.05),TS明显低于对照组(P<0.05)。在高血压合并糖代谢异常组内,HOMA-IR与TO、TS、SDNN、LEVDD有相关性(r=0.487,P=0.010;r=-0.187,P=0.040;r=-0.608,P=0.010;r=-0.236,P=0.043)。结论在老年高血压人群,糖代谢紊乱影响窦性心律震荡,可能为胰岛素抵抗加重自主神经功能损害所致。 Objective To investigate the changes of heart rate turbulence(HRT) in patients suffering from essential hypertension with different glucose tolerance in man and to explore the correlation between HRT and insulin resistance. Methods Seventy cases of essential hypertension combined with different glucose tolerance were enrolled in this study. All patients were monitored with 12-lead 24 h hoter. Turbulence onset (TO) and turbulence slope (TS) were calculated. Results TO in essential hypertension group rose significantly ( P 〈 0.05 ) with the increasing of blood glucose and TS decreased inversely. TO and TS are relevant with the insulin resistance index( HOMA-IR,P 〈0. 05). Conclusion In elderly male hypertensive patients, glucose metabolism disorders may influence the HRT, the autonomic nervous function is damaged with the insulin resistance.
出处 《中国临床保健杂志》 CAS 2013年第2期116-118,共3页 Chinese Journal of Clinical Healthcare
基金 安徽省卫生厅课题(2008B044)
关键词 高血压 心律失常 窦性 胰岛素抵抗 葡萄糖代谢障碍 Hypertension Arrhythmia, sinus Insulin resistance Glucose metabolism disorders
  • 相关文献

参考文献3

二级参考文献34

  • 1Koren M J, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991 ;114:345-352.
  • 2Takemono M, Node K, Nakagami H. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 2001 ;108: 1429-1437.
  • 3Ye P, Sheng L, Zhang C, Liu Y. Atorvastatin attenuating down-regulation of peroxisome proliferator-activated receptor gamma in preventing cardiac hypertrophy of rats in vitro and in vivo. J Pharm Pharm Sci 2006:9 : 365-375.
  • 4World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO), International Society of Hypertension (ISH) statement on management of hypertension (Guidelines and recommendations). J Hypertens 2003;21: 1983-1992.
  • 5Morley-davies A, Dargie H J, Cobbe SM, Schneider R, Schmidt G. Heart rate turbulence: a novel holter derived measure and mortality in chronic heart failure. Eur Heart J 2000:21:408-416.
  • 6Guo JH. Heart rate turbulence. J Clin Electrocardiol 2003;24:49-54.
  • 7De Simone G, Devereux RB, Camargo M J, Wallerson DC, Laragh JH. Midwall left ventricular performance in saltloaded Dahl rats: effect of AT1 angiotensin Ⅱ inhibition. J Hypertens1996;13:1808-1824.
  • 8Tedesco MA, Ratti G, Aquino D, Limongelli G, di Salvo G, Mennella S, et al. Effects of valsartan on hypertension and left ventricular mass: a long-term study. J Hum Hypertens 1998;24:505-510.
  • 9Dechend R, Fiebeler A, Park JK, Muller DN, Theuer J, Mervaala E, et al. Amelioration of angiotensin Ⅱ-induced cardiac injury by a 3-hydroxy-3-methylgutaryl coenzyme A reductase inhibitor. Circulation 2001 ;104:576-581.
  • 10Indolfi C, Di LE, Perrino C, Stingone AM, Curcio A, Torella D, et al. Hydroxymethylglutaryl coenzyme A reductase inhibitor Xuezhikang Capsules prevents cardiac hypertrophy induced by pressure overload and inhibits p21 ras activation. Circulation 2002;106:2118-2244.

共引文献64

同被引文献21

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部